Mucositis: pathobiology and management.

Abstract:

PURPOSE OF REVIEW:Oral mucositis remains a frequent debilitating toxicity associated with drug and radiation regimens used to treat cancer. This review highlights the recent understanding of the biological basis, risk factors for, and management for oral mucositis. RECENT FINDINGS:Prevalence and incidence data for mucositis are inconsistent and often underreported. The pathogenesis of mucositis encompasses a sequence of biological events possibly influenced by the oral microbiome and environment. Despite its frequency and severity, there is currently no effective treatment available for the majority of patients at risk. However, with the better understanding of the pathogenesis of mucositis a number of new drugs and biological agents are under investigation. Genome-wide risk prediction tools will allow the identification of patients at risk of developing mucositis. SUMMARY:Oral mucositis is a common complication of cancer treatment that may negatively impact the patient's cancer treatment outcome. Despite its frequency and consequences, the lack of effective interventions has frustrated patients and caregivers. Fortunately, a broad range of mechanistically targeted compounds are being developed.

journal_name

Curr Opin Oncol

authors

Villa A,Sonis ST

doi

10.1097/CCO.0000000000000180

subject

Has Abstract

pub_date

2015-05-01 00:00:00

pages

159-64

issue

3

eissn

1040-8746

issn

1531-703X

journal_volume

27

pub_type

杂志文章,评审
  • Testicular cancer.

    abstract::The rising rate of germ cell cancer of the testis over the past decade has been demonstrated to be occurring predominantly in the younger age group (15 to 19 years) in association with earlier onset of puberty and earlier onset of regular sexual activity. Chemicals and viruses, with their atrophogenic effect, remain t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199605000-00015

    authors: Oliver RT

    更新日期:1996-05-01 00:00:00

  • Treatment of AIDS-related lymphomas.

    abstract::Infection with HIV is associated with an increased risk of systemic and primary central nervous system non-Hodgkin's lymphoma. Patients with systemic non-Hodgkin's lymphoma usually present with high- or intermediate-grade histology and extranodal dissemination. Although the prognosis for such patients is poor, some pa...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Sparano JA

    更新日期:1995-09-01 00:00:00

  • Thyroid nodules: diagnosis and therapy.

    abstract::Less than 1% of all cancers are present in the thyroid, yet thyroid nodules are found in 4 to 10% of the adult population. Because thyroid nodules are relatively common, the diagnostic dilemma is to distinguish between a more common benign nodule, which usually does not require specific treatment, and a malignant nodu...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200201000-00009

    authors: Weiss RE,Lado-Abeal J

    更新日期:2002-01-01 00:00:00

  • High dose cytarabine or transplantation for consolidation of younger patients with acute myeloid leukemia.

    abstract::Collaborative study groups have invested considerable effort in the last decade in defining the role of allogeneic and autologous bone marrow transplantation as consolidation treatment for first remission of acute myeloid leukemia in younger patients. These efforts have been able, more precisely, to quantitate the deg...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200003000-00002

    authors: Burnett AK,Kell J

    更新日期:2000-03-01 00:00:00

  • Advances in prostate cancer.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to highlight the most important developments in the diagnosis, prevention, and management of prostate cancer reported in the past year that have been published in the medical literature. RECENT FINDINGS:Recent research has yielded important insights into the effects of l...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200405000-00009

    authors: Ryan CJ,Small EJ

    更新日期:2004-05-01 00:00:00

  • Testicular germ cell tumors.

    abstract:PURPOSE OF REVIEW:An overview of many of the preclinical and clinical developments in germ cell tumors over the past year is presented. RECENT FINDINGS:Recent epidemiologic studies show changes in the ethnic incidence of germ cell tumors; in particular, African-Americans have seen an increase. Additionally, risk facto...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000219257.37843.ca

    authors: Bridges B,Hussain A

    更新日期:2006-05-01 00:00:00

  • Immunotherapy-based combinations: an update.

    abstract:PURPOSE OF REVIEW:The advent of immunotherapy significantly improved clinical outcomes in cancer patients, although immune checkpoint blockade (ICB) still lack of efficacy in a consistent proportion of treated patients. The purpose of this article is to review the most innovative and clinically promising ICB-based comb...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000466

    authors: Fucà G,de Braud F,Di Nicola M

    更新日期:2018-09-01 00:00:00

  • The role of transoral robotic surgery in the management of oropharyngeal cancer.

    abstract:PURPOSE OF REVIEW:The rising incidence of oropharyngeal squamous cell carcinoma (OPSCC), in large part as a result of the human papillomavirus (HPV), has driven a movement for the change in the management strategies. Renewed interest in minimally invasive approaches of endoscopic head and neck surgery led to introducti...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/CCO.0000000000000365

    authors: Dias FL,Walder F,Leonhardt FD

    更新日期:2017-05-01 00:00:00

  • Recent advances in the management of mantle cell lymphoma.

    abstract:PURPOSE OF REVIEW:This review will discuss the most recent literature regarding frontline therapy, treatment of patients not eligible for intensive chemotherapy, and novel agents for relapsed/refractory patients with mantle cell lymphoma (MCL). RECENT FINDINGS:Longer follow-up of previously studied intensive regimens ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000010

    authors: Rivera-Rodriguez N,Cabanillas F

    更新日期:2013-11-01 00:00:00

  • Genetic causes of glioma: new leads in the labyrinth.

    abstract:PURPOSE OF REVIEW:A small percentage of gliomas are caused by inheritance in cancer syndromes but there is also a general familial aggregation of glioma. Recently, low penetrant genes associated with glioma risk have been identified. RECENT FINDINGS:Seven independent chromosomal loci have robustly been associated with...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32834a6f61

    authors: Melin B

    更新日期:2011-11-01 00:00:00

  • Molecular prediction of metastasis in cutaneous squamous cell carcinoma.

    abstract:PURPOSE OF REVIEW:Cutaneous squamous cell carcinoma (cSCC) is a highly prevalent malignancy frequently occurring on body surfaces chronically exposed to ultraviolet radiation. While a large majority of tumors remain localized to the skin and immediate subcutaneous tissue and are cured with surgical excision, a small su...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000609

    authors: Mulvaney PM,Schmults CD

    更新日期:2020-03-01 00:00:00

  • The next-generation ALK inhibitors.

    abstract:PURPOSE OF REVIEW:Crizotinib now is accepted as the standard first-line treatment of ALK-rearranged lung adenocarcinomas. To overcome the problem of crizotinib resistance, second-generation ALK inhibitors are in development. The aim of this review is to give an overview on the mechanisms behind crizotinib resistance an...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000165

    authors: Pall G

    更新日期:2015-03-01 00:00:00

  • Anal carcinoma: histology, staging, epidemiology, treatment.

    abstract::Our understanding of the pathogenesis and management of squamous cell carcinoma of the anal canal has undergone profound change over the last 30 years. Epidemiologic studies have demonstrated that infection with human papillomavirus is most likely responsible for the majority of cases. Primary treatment with concomita...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200007000-00011

    authors: Ryan DP,Mayer RJ

    更新日期:2000-07-01 00:00:00

  • Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer.

    abstract::The treatment options for patients with recurrent head and neck malignancies arising in a previously irradiated field are limited. Surgical salvage is feasible in a minority of patients. The majority are referred for palliative chemotherapy with no realistic chance for cure. Data are accumulating to support reirradiat...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200205000-00013

    authors: Garofalo MC,Haraf DJ

    更新日期:2002-05-01 00:00:00

  • Critical care management of cancer patients: cause for optimism and need for objectivity.

    abstract:PURPOSE OF REVIEW:In the 1990s, cancer patients were described as poor candidates for ICU admission on the basis of high mortality rates and management costs. Over the last decade, however, advances in the management of malignancies and organ failures have led to substantial increases in survival. This review discusses...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32832b68b6

    authors: Darmon M,Azoulay E

    更新日期:2009-07-01 00:00:00

  • Pediatric genitourinary tumors.

    abstract:PURPOSE OF REVIEW:To review the 2008-2009 literature on pediatric genitourinary tumors and highlight the most significant publications. RECENT FINDINGS:New techniques such as gene expression profiling, PET, nephron-sparing surgery, and stem cell transplantation are being incorporated into contemporary treatments for p...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833841a1

    authors: McLean TW,Buckley KS

    更新日期:2010-05-01 00:00:00

  • Mechanisms of invasion in glioblastoma.

    abstract:PURPOSE OF REVIEW:This review provides an overview of recent updates in understanding the mechanisms by which glioblastoma cells interact with their cellular and molecular partners within the microenvironment. RECENT FINDINGS:We have now a better knowledge of the cell populations involved in Glioblastoma (GBM) invasio...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/CCO.0000000000000679

    authors: Chouleur T,Tremblay ML,Bikfalvi A

    更新日期:2020-11-01 00:00:00

  • The changing scene of adult acute lymphoblastic leukemia.

    abstract:PURPOSE OF REVIEW:The review focuses on the most recent advances in the diagnostic and prognostic work-up of adult acute lymphoblastic leukemia (ALL) and its implications in the clinical management of the disease. RECENT FINDINGS:ALL can be identified on the basis of morphologic, cytochemical and immunophenotypic crit...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000245317.82391.1b

    authors: Vitale A,Guarini A,Chiaretti S,Foà R

    更新日期:2006-11-01 00:00:00

  • Brain metastases: current management and new developments.

    abstract:PURPOSE OF REVIEW:To review the state-of-the-art and new developments in the management of patients with brain metastases. RECENT FINDINGS:Treatment decisions are based on prognostic factors to maximize neurologic function and survival, while avoiding unnecessary therapies. Whole-brain radiotherapy (WBRT) is the treat...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32831186fe

    authors: Soffietti R,Rudà R,Trevisan E

    更新日期:2008-11-01 00:00:00

  • Temsirolimus in the treatment of mantle cell lymphoma: frequency and management of adverse effects.

    abstract:PURPOSE OF REVIEW:Temsirolimus (Torisel) is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of relapsed/refractory mantle cell lymphoma (MCL). The recommended dosage in this indication (175 mg once weekly for 3 weeks and then 75 mg once weekly as maintenance) is higher than that for renal ce...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835de8ee

    authors: Bouabdallah K,Ribrag V,Terriou L,Soria JC,Delarue R

    更新日期:2013-03-01 00:00:00

  • Digital quantification of mutant DNA in cancer patients.

    abstract:PURPOSE OF REVIEW:The accumulation of somatic mutations is the major driving force for tumorigenesis. These mutations uniquely differentiate tumor cells from their normal counterparts. Mutations within tumor cells and mutant DNA released by tumor cells into blood, lymph, stool, tissues and other bodily compartments can...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328011a8e7

    authors: Diehl F,Diaz LA Jr

    更新日期:2007-01-01 00:00:00

  • Targeting receptor activator of nuclear factor-kappa B as a new therapy for bone metastasis in non-small cell lung cancer.

    abstract:PURPOSE OF REVIEW:The review aims at comprehensively discussing our current knowledge on bone metastases incidence in non-small cell lung cancer (NSCLC), their related complications as well as clinical impact in patients suffering from advanced disease. RECENT FINDINGS:After evoking the use of zoledronic acid as the e...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32835d720b

    authors: Peters S,Meylan E

    更新日期:2013-03-01 00:00:00

  • Screening, staging, and diagnostic investigation of non-small cell lung cancer patients.

    abstract::Despite its appeal, lung cancer screening has been found to be of little value at this time. However, use of monoclonal antibodies to detect cancer cells in the sputum may prove to be of value in high-risk subjects. Once a cancer is diagnosed, anatomic staging by the International TNM Staging System has shown its effe...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199104000-00010

    authors: Shields TW

    更新日期:1991-04-01 00:00:00

  • Managing seminomatous and nonseminomatous germ cell tumors.

    abstract:PURPOSE OF REVIEW:In the present review, we summarize the recent developments in the management of germ cell tumors (GCTs). RECENT FINDINGS:Treatment-related acute and late-onset toxicity remains a key challenge in the management of GCTs, with recent evidence showing that the adverse health outcomes of etoposide and c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000446

    authors: Chahoud J,Zhang M,Shah A,Lin SH,Pisters LL,Tu SM

    更新日期:2018-05-01 00:00:00

  • Tackling immunomonitoring in gastrointestinal cancer.

    abstract:PURPOSE OF REVIEW:The growing awareness that the immune system is a key player in the antitumoral response and the excellent clinical results achieved in some settings with anti-programmed cell death 1 (PD1)/programmed death ligand 1 (PDL1) and anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) drugs has led to t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000383

    authors: Anciaux M,Vandeputte C,Hendlisz A

    更新日期:2017-07-01 00:00:00

  • An examination of recently revised differentiated thyroid cancer guidelines.

    abstract:PURPOSE OF REVIEW:To examine the most recent changes in published guidelines by various organizations for the treatment of patients with differentiated thyroid cancer. This document provides a comparison of recommendations for common topics currently found in available thyroid cancer care guidelines. RECENT FINDINGS:R...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833fc9c4

    authors: Miller BS,Doherty GM

    更新日期:2011-01-01 00:00:00

  • Recent developments in supporting adolescent and young adult siblings of cancer patients.

    abstract:PURPOSE OF REVIEW:The psychosocial needs of adolescent and young adult (AYA) siblings of cancer patients are easily overlooked. Accordingly, the evidence base informing short and long-term outcomes for these young people is sparse. This review provides an overview of recent research highlighting the experiences, unmet ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000194

    authors: Patterson P,Medlow S,McDonald FE

    更新日期:2015-07-01 00:00:00

  • New developments in bone marrow transplantation.

    abstract::A better understanding of the immunobiology after transplantation and of the available recombinant cytokines that enhance hematopoietic reconstitution following autologous and allogeneic bone marrow transplantation is likely to result in safer application of bone marrow transplantation. Residual tumor cells escaping c...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199104000-00005

    authors: Slavin S,Nagler A

    更新日期:1991-04-01 00:00:00

  • Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment.

    abstract:PURPOSE OF REVIEW:Primary thyroid lymphoma (PTL) is a rare but clinically important malignancy of the thyroid. This article reviews the diagnosis, histologic subtypes, pathogenesis, and treatment of PTL, with the objective of optimizing diagnosis and management of the disease. RECENT FINDINGS:Recent studies have shed ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283330848

    authors: Graff-Baker A,Sosa JA,Roman SA

    更新日期:2010-01-01 00:00:00

  • Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia.

    abstract::The bcr-abl fusion protein is present in the vast majority of cases of chronic myelogenous leukemia, and the deregulated tyrosine kinase activity of this protein is essential for leukemic transformation. Thus, bcr-abl is an ideal target for pharmacologic inhibition. In preclinical studies, ST1571 (formerly CGP57148B),...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200011000-00013

    authors: O'Dwyer ME,Druker BJ

    更新日期:2000-11-01 00:00:00